Current Opinion in Infectious Diseases

Article	Citations
Respiratory infections in lung transplant recipients	65
Omadacycline for the treatment of skin and soft tissue infections	39
Dermatological manifestations during Dengue, Chikungunya, and Zika infections	35
Recurrence of skin and soft tissue infections: identifying risk factors and treatment strategies	35
Mycobacterium abscessus group pulmonary disease	35
The next frontier: cytomegalovirus antiviral stewardship programs in solid organ transplant	31
Antiviral therapies for influenza	29
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians	29
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients	29
Infection prevention measures in acute care settings based on severe acute respiratory syndrome coronavirus 2 transmission patterns and risk: a review	26
Editorial introductions	26
Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections	26
How different is invasive fusariosis in pediatric patients than in adults? A systematic review	24
Strongyloidiasis-related lung involvement: too much of a bad thing	24
Editorial: Friends and foes: “The quarrels of friends are the opportunities of foes”	23
Editorial introductions	23
Editorial introductions	23
Surgical management of cystic echinococcosis of the liver	22
Neonatal complicated intraabdominal infection	22
The microbiome as a biomarker of anal precancerous lesions in people with HIV	21
Community-acquired skin and soft-tissue infections in people who inject drugs	20
Editorial introductions	20
Where was my patient born? The Intersection of tropical medicine and migrant health	19
Rectal chlamydia infections: implications for reinfection risk, screening, and treatment guidelines	18
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis	18

Update on drug treatments for multidrug resistant tuberculosis	17
Dengue vaccine development: challenges and prospects	17
La Crosse virus encephalitis in children	17
Prevention of SARS-CoV-2 and respiratory viral infections in healthcare settings: current and emerging concepts	17
What is the clinical significance of ‘heteroresistance’ in nonfermenting Gram-negative strains?	17
Transplantation for chagas’ disease: closing the knowledge gap	17
A new direction for cytomegalovirus prophylaxis among transplant recipients: Benefits and nonviral outcomes of letermovir use as primary CMV prophylaxis	17
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans	17
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	17
Current challenges in acute bacterial skin infection management	16
Choosing antibiotic therapy for severe community-acquired pneumonia	16
Completion of multidose vaccine series in early childhood: current challenges and opportunities	15
An overview of risk factors, management and prevention of cochlear implant infections	15
Mucormycosis: update on clinical presentation, diagnosis, and treatment	14
Neurocysticercosis: an update on diagnosis, treatment, and prevention	14
Not all carbapenem-resistant Pseudomonas aeruginosa strains are alike: tailoring antibiotic therapy based on resistance mechanisms	14
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era	14
Editorial introductions	14
From diagnosis to management: current perspectives on congenital cytomegalovirus infection	14
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel	14
Skin and soft tissue infections in the elderly	14
Update on diagnosis and treatment of fungal meningitis: lessons from recent outbreaks	14
Amebic encephalitis and meningoencephalitis: an update on epidemiology, diagnostic methods, and treatment	13
Clinical evidence supporting cefiderocol for serious Acinetobacter baumannii infections	13
Alveolar echinococcosis: what triggers emergence in North America, Central Europe and Asia?	13
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV	13
Complexities of cardiomyopathy in septic shock	13
Frailty in people living with HIV: an update	12
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives	12
Respiratory metagenomics: route to routine service	12
Short treatment duration for community-acquired pneumonia	11
Progress and challenges in human papillomavirus and cervical cancer in southern Africa	11
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes	11
The disease burden of respiratory syncytial virus in Infants	11
Typhoid fever control in the 21st century: where are we now?	10
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?	10
Editorial introductions	10
A new era of HIV care for age-associated multimorbidity	10
Editorial introductions	10
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings	10
Biomarkers to predict cardiovascular disease in people living with HIV	10
Pathogenesis and immune response: editorial Biomedical research discoveries: acceptance, controversies and current challenges to improving human health	9
Modeling transmission of pathogens in healthcare settings	9
Prevention and treatment of C. difficile in cancer patients	9
Impact of health disparity on pediatric infections	9
How to use new antibiotics in the therapy of ventilator-associated pneumonia	9
Respiratory protection: what SARS-CoV-2 has taught us	9
Antifungal hypersensitivity reactions and cross-reactivity patterns	9
Risk factors for severity in seasonal respiratory viral infections and how they guide management in hematopoietic cell transplant recipients	8
COVID19 in hematological patients and telemedicine: lessons learned across Europe and the US	8

The role of Gram-negative bacteria in skin and soft tissue infections	8
Novel techniques in the treatment of skin and soft tissue infection	8
Current treatment options for pneumonia caused by carbapenem-resistant Acinetobacter baumannii	8
Clinical and microbiological characteristics of Staphylococcus lugdunensis	8
New therapies for nontuberculous mycobacterial lung infection	8
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management	8
Prevention and treatment of recurrent cellulitis	8
The future of Clostridioides difficile diagnostics	8
Identifying patients with difficult-to-treat acute bacterial skin infections	8
Novel agents in development for multidrug-resistant Gram-negative infections: potential new options facing multiple challenges	7
Skin manifestations in patients with coronavirus disease 2019	7
Risk factors for cognitive decline in persons with HIV	7
Respiratory syncytial virus infection in the modern era	7
Severe acute respiratory syndrome coronavirus 2 infection in the stem cell transplant recipient − clinical spectrum and outcome	7
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?	7
Community engagement tools in HIV/STI prevention research	7
The disease burden of respiratory syncytial virus in older adults	7
Fusarium species central nervous system infection	7
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response	7
Viral meningitis and encephalitis: an update	7
Bacteriophages against enteropathogens: rediscovery and refinement of novel antimicrobial therapeutics	7
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	7
Duration of antifungal treatment in mold infection: when is enough?	7
Inborn errors of immunity and invasive fungal infections: presentation and management	7
Novel approaches to the prediction and diagnosis of pulmonary complications in the paediatric haematopoietic stem cell transplant patient	7
Host transcriptional signatures as predictive markers of infection in children	7
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections	7
Editorial: humans versus pathogens: a persistent battle	7
Current international and national guidelines for managing skin and soft tissue infections	7
Editorial introductions	7
Short-course antibiotic strategies for ventilator-associated pneumonia	7
Mycobacterial skin infection	7
Monoclonal antibodies for prophylaxis and treatment of respiratory viral infections	7
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	7
How to use new antibiotics in the therapy of serious multidrug resistant Gram-negative infections?	6
The power of story: what Victorian novels can teach us about public health	6
Editorial introductions	6
Neurobrucellosis	6
Melioidosis and Burkholderia pseudomallei: progress in epidemiology, diagnosis, treatment and vaccination	6
Donors with human immunodeficiency virus and hepatitis C virus for solid organ transplantation: what's new	6
Gambiense human African trypanosomiasis: the bumpy road to elimination	6
Climate change and resilience for antimicrobial stewardship and infection prevention	6
Skin and soft tissue infections in solid organ transplants	6
Aseptic meningitis: a foundation review	6
New approaches to management of fever and neutropenia in high-risk patients	6
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?	6
Horizontal versus vertical strategies for infection prevention: current practices and controversies	6
Burden of influenza in the elderly: a narrative review	6
Brain abscess in immunocompetent patients: recent findings	6
Duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli	5
Tuberculosis molecular bacterial load assay in the management of tuberculosis	5
Antibiotic treatment of acute bacterial skin and skin structure infections	5
Editorial: Transplant infectious disease landscape in the COVID19-Era	5
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity	5
Staphylococcus aureus infections in children	5
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies	5
Endemic parasitic infections in donors and recipients of stem cell and solid organ transplants: focus on strongyloidiasis and Chagas disease	5
Editorial introductions	5
Wastewater-based epidemiology for surveillance of infectious diseases in healthcare settings	5
The future approach for the management of acute bacterial skin and skin structure infections	5
Mpox primer for clinicians: what makes the difference in 2024?	5
The front-line during the coronavirus disease 2019 pandemic: healthcare personnel	5
Reasons for optimism in respiratory infections	5
Editorial introductions	5
Multidrug-resistant, gram-negative infections in high-risk haematologic patients: an update on epidemiology, diagnosis and treatment	4
Pulmonary cystic echinococcosis	4
Current challenges in neurocysticercosis: recent data and where we are heading	4
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention	4
Noninfectious causes of fever in hematologic malignancies. Are antibiotics still indicated?	4
Malaria in pregnancy: baby steps	4
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention	4
The microbiology and pathogenesis of nonfermenting Gram-negative infections	4
Viral diarrheas – newer advances in diagnosis and management	4
Mpox in people living with HIV	4
Watch-and-wait approach for inactive echinococcal cysts: scoping review update since the issue of the WHO-IWGE Expert Consensus and current perspectives	4
Chagas disease in the immunocompromised host	4
Immune responses and severe dengue: what have we learned?	4
Pregnancy and malaria: the perfect storm	4
Current viewpoint on the epidemiology of nonfermenting Gram-negative bacterial strains	4
Percutaneous treatment of liver hydatid cysts: to PAIR or not to PAIR	4

Solid organ transplant-related central nervous system infections	4
Editorial introductions	4
Resistance in Enteric Shigella and nontyphoidal Salmonella: emerging concepts	4
Strongyloides stercoralis infection in solid organ transplant recipients	4
Progress towards effective vaccines for Chlamydia trachomatis	3
Reexploring cytomegalovirus serology in allogeneic hematopoietic cell transplantation	3
The many faces of brucellosis: diagnostic and management approach	3
Coronavirus disease 2019 vaccination in transplant recipients	3
Resistant herpes simplex virus infections – who, when, and what's new?	3
Siderophores: a potential role as a diagnostic for invasive fungal disease	3
Neurodevelopmental outcomes in congenital and perinatal infections	3
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients	3
Managing cognitive impairment in people with HIV	3
The evolution of knowledge for treating Gram-negative bacterial infections	3
Long COVID in children and adolescents	3
Controversies over the management of infections caused by Amp-C- and ESBL-producing Enterobacterales: what questions remain for future studies?	3
The role of older antibiotics in the treatment of skin and soft tissue infections: current perspectives	3
Therapeutic agents for the treatment of human mpox	3
Viral infections and inborn errors of immunity	3
Chains of misery: surging invasive group A streptococcal disease	3
Techniques in bacterial strain typing: past, present, and future	3
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?	3
Tick-borne encephalitis	3
Appropriate surgical management in skin and soft tissue infections	3